Digital Digitalisation of pharma in 2025: What’s holding firms back? The ability to operate with real-time data, integrated systems, and validated automation is now essential.
Views & Analysis In the healthcare and life sciences jungle – industry must a... As the digital revolution takes hold, life sciences companies must evolve or face the consequences.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
